257 related articles for article (PubMed ID: 33303079)
1. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week.
Cainzos-Achirica M; Glassner K; Zawahir HS; Dey AK; Agrawal T; Quigley EMM; Abraham BP; Acquah I; Yahya T; Mehta NN; Nasir K
J Am Coll Cardiol; 2020 Dec; 76(24):2895-2905. PubMed ID: 33303079
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation.
Weissman S; Sinh P; Mehta TI; Thaker RK; Derman A; Heiberger C; Qureshi N; Amrutiya V; Atoot A; Dave M; Tabibian JH
World J Gastrointest Pathophysiol; 2020 Aug; 11(5):104-113. PubMed ID: 32832194
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?
Bigeh A; Sanchez A; Maestas C; Gulati M
Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485
[TBL] [Abstract][Full Text] [Related]
4. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease.
Lee MT; Mahtta D; Chen L; Hussain A; Al Rifai M; Sinh P; Khalid U; Nasir K; Ballantyne CM; Petersen LA; Virani SS
Am J Med; 2021 Aug; 134(8):1047-1051.e2. PubMed ID: 33812865
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey.
Nasir K; Acquah I; Dey AK; Agrawal T; Hassan SZ; Glassner K; Abraham B; Quigley EMM; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Cainzos-Achirica M; Mehta NN
Am J Prev Cardiol; 2022 Mar; 9():100316. PubMed ID: 35112094
[TBL] [Abstract][Full Text] [Related]
6. [Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease].
Mironova OI; Isaikina MA; Khasieva SA
Ter Arkh; 2021 Dec; 93(12):1533-1538. PubMed ID: 36286684
[TBL] [Abstract][Full Text] [Related]
7. The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis.
Garshick M; Underberg JA
Curr Atheroscler Rep; 2017 Oct; 19(12):48. PubMed ID: 29038899
[TBL] [Abstract][Full Text] [Related]
8. Is there a cardiovascular risk in inflammatory bowel diseases?
Mitu O; Alexandrescu DM; Cătălina M; Cristina CP
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):918-23. PubMed ID: 25581948
[TBL] [Abstract][Full Text] [Related]
9. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
Rungoe C; Basit S; Ranthe MF; Wohlfahrt J; Langholz E; Jess T
Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular implications of inflammatory bowel disease: An updated review.
Bhardwaj A; Singh A; Midha V; Sood A; Wander GS; Mohan B; Batta A
World J Cardiol; 2023 Nov; 15(11):553-570. PubMed ID: 38058397
[TBL] [Abstract][Full Text] [Related]
11. Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?
Mahtta D; Khalid U; Misra A; Samad Z; Nasir K; Virani SS
Curr Atheroscler Rep; 2020 Jul; 22(9):44. PubMed ID: 32671484
[TBL] [Abstract][Full Text] [Related]
12. The risk of cardiovascular complications in inflammatory bowel disease.
Czubkowski P; Osiecki M; Szymańska E; Kierkuś J
Clin Exp Med; 2020 Nov; 20(4):481-491. PubMed ID: 32785793
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease.
Agrawal T; Acquah I; Dey AK; Glassner K; Abraham B; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Mehta N; Quigley EM; Cainzos-Achirica M; Nasir K
Am J Prev Cardiol; 2021 Jun; 6():100171. PubMed ID: 34327497
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management.
Sleutjes JAM; van Lennep JER; van der Woude CJ; de Vries AC
Therap Adv Gastroenterol; 2021; 14():17562848211032126. PubMed ID: 34377149
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors.
Alenghat FJ
Sci Rep; 2016 Feb; 6():20303. PubMed ID: 26842423
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, risk factors and management of cardiovascular diseases in IBD.
Singh S; Kullo IJ; Pardi DS; Loftus EV
Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):26-35. PubMed ID: 25446727
[TBL] [Abstract][Full Text] [Related]
17. Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.
Marchioni Beery RM; Barnes EL; Nadkarni A; Korzenik JR
Inflamm Bowel Dis; 2017 Dec; 24(1):25-34. PubMed ID: 29272476
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876
[TBL] [Abstract][Full Text] [Related]
19. Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease.
Lee MT; Mahtta D; Alam M; Ullah W; Nasir K; Hanif B; Virani SS
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):559-570. PubMed ID: 33565901
[No Abstract] [Full Text] [Related]
20. Comorbidities in inflammatory bowel disease: a call for action.
Argollo M; Gilardi D; Peyrin-Biroulet C; Chabot JF; Peyrin-Biroulet L; Danese S
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):643-654. PubMed ID: 31171484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]